Pfizer (PFE) Tops Q2 EPS by 9c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $29.85 -0.86%
EPS Growth %: -16.1%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: -16.1%
Financial Fact:
Selling, informational and administrative expenses: 3.56B
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $15.03 billion versus the consensus estimate of $14.42 billion.
GUIDANCE:
Pfizer sees FY2026 EPS of $2.80-$3.00, versus the consensus of $2.95.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Getty Realty (GTY) Tops Q3 EPS by 5c
- Lake Shore Bancorp (LSBK) Tops Q3 EPS by 31c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
